EMA Needs More Cases To Assess Value Of Involving Patients In CHMP Meetings
This article was originally published in SRA
Executive Summary
The European Medicines Agency is extending an ongoing pilot project in which it invites patients to take part in certain meetings that its human medicines committee, the CHMP, holds to discuss the benefits and risks of drugs.